🆕
globalhealthconnector.com
20/06/2026
New European Project PHOENIX launches to develop safer treatments for children with high-risk cancer | Global Health Connector
EU-funded PHOENIX launches Phase I/II trial of oral ibrilatazar for relapsed neuroblastoma and paediatric solid tumours to improve safety and outcomes.